stockportfolio.pro
Stocks / HCA vs VRTX
HCA vs VRTX
HCA Healthcare, Inc. and Vertex Pharmaceuticals Incorporated side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| HCA Healthcare, Inc. (HCA) | Vertex Pharmaceuticals Incorporated (VRTX) | |
|---|---|---|
| Market cap | $86.5B | $114.3B |
| Revenue (latest FY) | $75.60B | $12.00B |
| Net income (latest FY) | $6.78B | $3.95B |
| Revenue growth (5y CAGR) | 8.0% | 14.1% |
| Net margin | 9.0% | 32.9% |
| Return on equity | -112.6% | 21.2% |
| P/E ratio | 13.3 | 26.7 |
| Dividend yield | 0.8% | — |
| Profitable years (of last 10) | 10 | 8 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open HCA — free Open VRTX — freeFrequently asked questions
Which is bigger, HCA or VRTX?
Vertex Pharmaceuticals Incorporated is larger by market capitalization — $114.3B versus $86.5B.
Which grows faster, HCA or VRTX?
Over the last five fiscal years, Vertex Pharmaceuticals Incorporated grew revenue faster — 14.1%/yr versus 8.0%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.